Key among these is interleukin-10 (IL-10), which is secreted predominantly by activated B-cell-like DLBCL (ABC-DLBCL) and fosters an immunosuppressive environment that supports tumor growth, with high IL-10 levels correlating with poor prognosis and treatment resistance [30,31]. Here, IL10 is linked to diffuse large B-cell lymphoma.